152 related articles for article (PubMed ID: 37927481)
1. Partial N-acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management.
Abou Haidar L; Pachnis P; Gotway GK; Ni M; DeBerardinis RJ; McNutt MC
JIMD Rep; 2023 Nov; 64(6):403-409. PubMed ID: 37927481
[TBL] [Abstract][Full Text] [Related]
2. Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia.
Häberle J
Expert Rev Endocrinol Metab; 2012 May; 7(3):263-271. PubMed ID: 30780843
[TBL] [Abstract][Full Text] [Related]
3. Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.
Häberle J
Ther Clin Risk Manag; 2011; 7():327-32. PubMed ID: 21941437
[TBL] [Abstract][Full Text] [Related]
4. N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.
Ah Mew N; Caldovic L
Appl Clin Genet; 2011; 4():127-35. PubMed ID: 23776373
[TBL] [Abstract][Full Text] [Related]
5. Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid-induced Hyperammonemia: A Rare Case Report.
Sattar Y; Wasiq S; Yasin W; Khan AM; Adnan M; Shrestha S; Patel NB; Latchana S
Cureus; 2018 Sep; 10(9):e3292. PubMed ID: 30443462
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency.
Singh RH; Bourdages MH; Kurtz A; MacLoed E; Norman C; Ratko S; van Calcar SC; Kenneson A
Orphanet J Rare Dis; 2024 Apr; 19(1):168. PubMed ID: 38637895
[TBL] [Abstract][Full Text] [Related]
7. Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid.
Lazier J; Lupichuk SM; Sosova I; Khan AA
Curr Oncol; 2014 Oct; 21(5):e736-9. PubMed ID: 25302046
[TBL] [Abstract][Full Text] [Related]
8. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
Kenneson A; Singh RH
Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
[TBL] [Abstract][Full Text] [Related]
9. New developments in the treatment of hyperammonemia: emerging use of carglumic acid.
Daniotti M; la Marca G; Fiorini P; Filippi L
Int J Gen Med; 2011 Jan; 4():21-8. PubMed ID: 21403788
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders.
Chapel-Crespo CC; Diaz GA; Oishi K
Expert Rev Endocrinol Metab; 2016; 11(6):467-473. PubMed ID: 30034506
[TBL] [Abstract][Full Text] [Related]
11. The Study of Carbamoyl Phosphate Synthetase 1 Deficiency Sheds Light on the Mechanism for Switching On/Off the Urea Cycle.
Díez-Fernández C; Gallego J; Häberle J; Cervera J; Rubio V
J Genet Genomics; 2015 May; 42(5):249-60. PubMed ID: 26059772
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the N-acetyltransferase domain of human N-acetyl-L-glutamate synthase in complex with N-acetyl-L-glutamate provides insights into its catalytic and regulatory mechanisms.
Zhao G; Jin Z; Allewell NM; Tuchman M; Shi D
PLoS One; 2013; 8(7):e70369. PubMed ID: 23894642
[TBL] [Abstract][Full Text] [Related]
13. A novel UPLC-MS/MS based method to determine the activity of N-acetylglutamate synthase in liver tissue.
Dercksen M; Duran M; IJlst L; Kulik W; Ruiter JP; van Cruchten A; Tuchman M; Wanders RJ
Mol Genet Metab; 2016 Dec; 119(4):307-310. PubMed ID: 27771289
[TBL] [Abstract][Full Text] [Related]
14. Early care of
Peoc'h K; Damaj L; Pelletier R; Lefèvre C; Dubourg C; Denis MC; Bendavid C; Odent S; Moreau C
Mol Genet Metab Rep; 2020 Mar; 22():100558. PubMed ID: 32021803
[No Abstract] [Full Text] [Related]
15. N-acetylglutamate synthase deficiency: Novel mutation associated with neonatal presentation and literature review of molecular and phenotypic spectra.
Al Kaabi EH; El-Hattab AW
Mol Genet Metab Rep; 2016 Sep; 8():94-8. PubMed ID: 27570737
[TBL] [Abstract][Full Text] [Related]
16. Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults.
Cartagena A; Prasad AN; Rupar CA; Strong M; Tuchman M; Ah Mew N; Prasad C
Can J Neurol Sci; 2013 Jan; 40(1):3-9. PubMed ID: 23250120
[TBL] [Abstract][Full Text] [Related]
17. Normal Neurological Development During Infancy Despite Massive Hyperammonemia in Early Treated NAGS Deficiency.
Reigstad H; Woldseth B; Häberle J
JIMD Rep; 2017; 37():45-47. PubMed ID: 28275973
[TBL] [Abstract][Full Text] [Related]
18. Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene.
Häberle J; Moore MB; Haskins N; Rüfenacht V; Rokicki D; Rubio-Gozalbo E; Tuchman M; Longo N; Yandell M; Andrews A; AhMew N; Caldovic L
Hum Mutat; 2021 Dec; 42(12):1624-1636. PubMed ID: 34510628
[TBL] [Abstract][Full Text] [Related]
19. Novel compound heterozygote variants: c.4193_4206delinsG (p.Leu1398Argfs*25), c.793C > A (p.Pro265Thr), in the CPS1 gene (NM_001875.4) causing late onset carbamoyl phosphate synthetase 1 deficiency-Lessons learned.
Lin HT; Enchautegui-Colon Y; Huang YR; Zimmerman C; DeMarzo D; Tsai AC
Mol Genet Metab Rep; 2022 Dec; 33():100942. PubMed ID: 36466970
[TBL] [Abstract][Full Text] [Related]
20. Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency.
Gessler P; Buchal P; Schwenk HU; Wermuth B
Eur J Pediatr; 2010 Feb; 169(2):197-9. PubMed ID: 19533169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
